David Nutt

Chief Research Officer at Awakn Life Sciences

David is a psychiatrist and the Edmund J. Safra Professor of Neuropsychopharmacology in the Division of Brain Science, Dept of Medicine, Imperial College London. Here he uses a range of brain imaging techniques to explore the causes of addiction and other psychiatric disorders and to search for new treatments. He has published over 400 original research papers, a similar number of reviews and books chapters, eight government reports on drugs, and 28 books, including one for the general public, Drugs: Without The Hot Air, that won the Transmission Prize in 2014.

He is currently the President of the European Brain Council and Founding Chair of Drug Science. Previously he has been president of the British Association of Psychopharmacology, the British Neuroscience Association, and the European College of Neuropsychopharmacology. He broadcasts widely to the general public both on radio and television. In 2010 The Times Eureka science magazine voted him one of the 100 most important figures in British Science, and the only psychiatrist on the list. In 2013 he was awarded the John Maddox Prize from Nature/Sense about Science for standing up for science.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Awakn Life Sciences

Awakn Life Sciences is a biotechnology company focused on research, development, and delivery of psychedelic medicines for the treatment of mental health conditions.


Industries

Headquarters

Toronto, Canada

Employees

11-50

Links